Literature DB >> 24487277

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Marco Gerlinger1, Stuart Horswell2, James Larkin3, Andrew J Rowan1, Max P Salm2, Ignacio Varela4, Rosalie Fisher3, Nicholas McGranahan1, Nicholas Matthews5, Claudio R Santos1, Pierre Martinez1, Benjamin Phillimore5, Sharmin Begum5, Adam Rabinowitz5, Bradley Spencer-Dene6, Sakshi Gulati7, Paul A Bates7, Gordon Stamp6, Lisa Pickering3, Martin Gore3, David L Nicol8, Steven Hazell9, P Andrew Futreal10, Aengus Stewart2, Charles Swanton1,11.   

Abstract

Clear cell renal carcinomas (ccRCCs) can display intratumor heterogeneity (ITH). We applied multiregion exome sequencing (M-seq) to resolve the genetic architecture and evolutionary histories of ten ccRCCs. Ultra-deep sequencing identified ITH in all cases. We found that 73-75% of identified ccRCC driver aberrations were subclonal, confounding estimates of driver mutation prevalence. ITH increased with the number of biopsies analyzed, without evidence of saturation in most tumors. Chromosome 3p loss and VHL aberrations were the only ubiquitous events. The proportion of C>T transitions at CpG sites increased during tumor progression. M-seq permits the temporal resolution of ccRCC evolution and refines mutational signatures occurring during tumor development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487277      PMCID: PMC4636053          DOI: 10.1038/ng.2891

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  43 in total

1.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

2.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

3.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers.

Authors:  Sohrab P Shah; Andrew Roth; Rodrigo Goya; Arusha Oloumi; Gavin Ha; Yongjun Zhao; Gulisa Turashvili; Jiarui Ding; Kane Tse; Gholamreza Haffari; Ali Bashashati; Leah M Prentice; Jaswinder Khattra; Angela Burleigh; Damian Yap; Virginie Bernard; Andrew McPherson; Karey Shumansky; Anamaria Crisan; Ryan Giuliany; Alireza Heravi-Moussavi; Jamie Rosner; Daniel Lai; Inanc Birol; Richard Varhol; Angela Tam; Noreen Dhalla; Thomas Zeng; Kevin Ma; Simon K Chan; Malachi Griffith; Annie Moradian; S-W Grace Cheng; Gregg B Morin; Peter Watson; Karen Gelmon; Stephen Chia; Suet-Feung Chin; Christina Curtis; Oscar M Rueda; Paul D Pharoah; Sambasivarao Damaraju; John Mackey; Kelly Hoon; Timothy Harkins; Vasisht Tadigotla; Mahvash Sigaroudinia; Philippe Gascard; Thea Tlsty; Joseph F Costello; Irmtraud M Meyer; Connie J Eaves; Wyeth W Wasserman; Steven Jones; David Huntsman; Martin Hirst; Carlos Caldas; Marco A Marra; Samuel Aparicio
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

4.  Tumour evolution inferred by single-cell sequencing.

Authors:  Nicholas Navin; Jude Kendall; Jennifer Troge; Peter Andrews; Linda Rodgers; Jeanne McIndoo; Kerry Cook; Asya Stepansky; Dan Levy; Diane Esposito; Lakshmi Muthuswamy; Alex Krasnitz; W Richard McCombie; James Hicks; Michael Wigler
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

5.  Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.

Authors:  Sohye Kang; Andreas G Bader; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

6.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

Authors:  J G Herman; F Latif; Y Weng; M I Lerman; B Zbar; S Liu; D Samid; D S Duan; J R Gnarra; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Authors:  K Foster; A Prowse; A van den Berg; S Fleming; M M Hulsbeek; P A Crossey; F M Richards; P Cairns; N A Affara; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

8.  Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas.

Authors:  Christina Thirlwell; Olivia C C Will; E Domingo; Trevor A Graham; Stuart A C McDonald; Dahmane Oukrif; Rosemary Jeffrey; Maggie Gorman; Manuel Rodriguez-Justo; Joanne Chin-Aleong; Sue K Clark; Marco R Novelli; Janusz A Jankowski; Nicholas A Wright; Ian P M Tomlinson; Simon J Leedham
Journal:  Gastroenterology       Date:  2010-01-25       Impact factor: 22.682

9.  Genetic variegation of clonal architecture and propagating cells in leukaemia.

Authors:  Kristina Anderson; Christoph Lutz; Frederik W van Delft; Caroline M Bateman; Yanping Guo; Susan M Colman; Helena Kempski; Anthony V Moorman; Ian Titley; John Swansbury; Lyndal Kearney; Tariq Enver; Mel Greaves
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962

10.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.

Authors:  Simon A Forbes; Nidhi Bindal; Sally Bamford; Charlotte Cole; Chai Yin Kok; David Beare; Mingming Jia; Rebecca Shepherd; Kenric Leung; Andrew Menzies; Jon W Teague; Peter J Campbell; Michael R Stratton; P Andrew Futreal
Journal:  Nucleic Acids Res       Date:  2010-10-15       Impact factor: 16.971

View more
  546 in total

1.  Gastrointestinal cancer: Tracking tumour evolution through liquid biopsy.

Authors:  Samra Turajlic; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2015-09-08       Impact factor: 66.675

Review 2.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

3.  Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.

Authors:  David J VanderWeele; Richard Finney; Kotoe Katayama; Marc Gillard; Gladell Paner; Seiya Imoto; Rui Yamaguchi; David Wheeler; Justin Lack; Maggie Cam; Andrea Pontier; Yen Thi Minh Nguyen; Kazuhiro Maejima; Aya Sasaki-Oku; Kaoru Nakano; Hiroko Tanaka; Donald Vander Griend; Michiaki Kubo; Mark J Ratain; Satoru Miyano; Hidewaki Nakagawa
Journal:  Eur Urol Focus       Date:  2018-02-15

4.  Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.

Authors:  Yuchao Jiang; Yu Qiu; Andy J Minn; Nancy R Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

5.  Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma.

Authors:  Xin Gao; Opeyemi Jegede; Connor Gray; Paul J Catalano; Jesse Novak; David J Kwiatkowski; Rana R McKay; Daniel J George; Toni K Choueiri; David F McDermott; Sabina Signoretti; Rupal S Bhatt
Journal:  Clin Genitourin Cancer       Date:  2018-04-25       Impact factor: 2.872

6.  Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model.

Authors:  Xi Chen; Zhiguo Zhou; Raquibul Hannan; Kimberly Thomas; Ivan Pedrosa; Payal Kapur; James Brugarolas; Xuanqin Mou; Jing Wang
Journal:  Phys Med Biol       Date:  2018-10-24       Impact factor: 3.609

7.  Deep sequencing reveals microRNAs predictive of antiangiogenic drug response.

Authors:  Jesús García-Donas; Benoit Beuselinck; Lucía Inglada-Pérez; Osvaldo Graña; Patrick Schöffski; Agnieszka Wozniak; Oliver Bechter; Maria Apellániz-Ruiz; Luis Javier Leandro-García; Emilio Esteban; Daniel E Castellano; Aranzazu González Del Alba; Miguel Angel Climent; Susana Hernando; José Angel Arranz; Manuel Morente; David G Pisano; Mercedes Robledo; Cristina Rodriguez-Antona
Journal:  JCI Insight       Date:  2016-07-07

Review 8.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

9.  Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.

Authors:  Amalie Kai Bentzen; Andrea Marion Marquard; Rikke Lyngaa; Sunil Kumar Saini; Sofie Ramskov; Marco Donia; Lina Such; Andrew J S Furness; Nicholas McGranahan; Rachel Rosenthal; Per Thor Straten; Zoltan Szallasi; Inge Marie Svane; Charles Swanton; Sergio A Quezada; Søren Nyboe Jakobsen; Aron Charles Eklund; Sine Reker Hadrup
Journal:  Nat Biotechnol       Date:  2016-08-29       Impact factor: 54.908

Review 10.  Tumour heterogeneity and metastasis at single-cell resolution.

Authors:  Devon A Lawson; Kai Kessenbrock; Ryan T Davis; Nicholas Pervolarakis; Zena Werb
Journal:  Nat Cell Biol       Date:  2018-11-26       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.